Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Asthma is increasing in prevalence worldwide and results in significant use of healthcare resources. Although most patients with asthma can be adequately treated with inhaled corticosteroids, an important number of patients require additional therapy and an increasing number of options are available. A further minority of patients develop severe persistent asthma which remains difficult to manage despite current pharmacological therapies. This review discusses the various treatment options currently available for each stage of asthma severity, highlights some of the limitations of current management, and outlines directions which may improve the management of asthma in the future.


Journal article


Postgrad Med J

Publication Date





259 - 267


Adrenal Cortex Hormones, Adrenergic beta-2 Receptor Antagonists, Allergens, Anti-Asthmatic Agents, Antibodies, Monoclonal, Asthma, Forecasting, Humans, Immunotherapy, Interleukins, Leukotriene Antagonists, Respiratory Therapy, Self Care, Smoking Cessation, Theophylline